Executive Summary & Key Takeaways
- Strategic Transaction: Project Farma, a global manufacturing services division of PerkinElmer, has acquired Cork-headquartered manufacturing automation and GMP IT provider SimoTech Group.
- Legal Advisory: Lead Irish legal advisory was provided by William Fry, with the corporate team led by Partner Ivor Banim. U.S. legal counsel was provided by Simpson Thacher & Bartlett, and Wong Partnership advised on Singaporean law.
- Industry Consolidation: The acquisition merges Project Farma's extensive commissioning, qualification, and validation (CQV) capabilities with SimoTech's specialized automation design, Manufacturing Execution Systems (MES), and Distributed Control Systems (DCS) engineering.
- Operational Continuity: Founded in 2011 by Pat Desmond, SimoTech will continue its operations in Cork, maintaining existing management teams and client-delivery partnerships.
In a significant consolidation within the global life science manufacturing and engineering services sector, Project Farma, a leading provider of Good Manufacturing Practice (GMP) services owned by PerkinElmer, has entered into a definitive agreement to acquire SimoTech Group (registered as PDAS Limited). The transaction represents a key strategic step for both companies, combining Project Farma’s expertise in facility commissioning, qualification, and validation (CQV) with SimoTech's deep expertise in manufacturing automation and digital IT systems.
Irish corporate law firm William Fry served as lead legal counsel to PerkinElmer, managing a multi-jurisdictional advisory structure that reflects the global footprint of both organizations. The transaction highlights the rising demand for integrated engineering and digital manufacturing services in the biopharmaceutical sector, where companies are increasingly seeking single-source solutions to guide facility design, validation, and operational deployment.
The Strategic Rationale: CQV Meets Digital Automation
Modern biopharmaceutical facilities are highly complex, relying on automated control loops, paperless documentation, and complex data infrastructures. Bringing a new manufacturing line from concept to commercial production requires two distinct but highly interdependent engineering capabilities: physical validation and digital automation systems.
Historically, drug developers have engaged separate contractors to manage these domains. Project Farma has established a reputation for its capabilities in facility startup, CQV, project management, and quality compliance. Conversely, Cork-based SimoTech has spent over a decade establishing itself as a premier partner for advanced manufacturing automation and GMP IT systems, focusing on systems such as Distributed Control Systems (DCS), Manufacturing Execution Systems (MES), and Supervisory Control and Data Acquisition (SCADA) systems.
By bringing SimoTech into the PerkinElmer family, the combined entity can offer life science developers a unified, end-to-end operational readiness platform. This integrated approach is expected to reduce project risk, optimize timelines, and ensure that new facilities meet global regulatory standards, including HPRA, EMA, and FDA compliance, on an accelerated schedule.
SimoTech’s Track Record in Irish and Global Life Sciences
Founded in 2011 by automation industry veteran Pat Desmond, SimoTech has grown from a specialized local consultancy into a major international systems integrator. Headquartered in Cork, the company employs a large team of automation engineers, system analysts, and GMP IT experts who service many of the world's largest pharmaceutical, biotech, and medical device manufacturers.
SimoTech’s success is rooted in its ability to translate complex manufacturing processes into robust, automated digital workflows. Its engineers design and implement the software and hardware architectures that control bioreactors, purification columns, formulation suites, and packaging lines. Over the years, the company has played a key role in several major capital expenditure projects across Ireland's biopharma hubs, including Cork, Dublin, and Galway, establishing a strong reputation for delivery under strict quality guidelines.
Under the terms of the transaction, SimoTech will continue to operate from its Cork offices, maintaining its current leadership team and customer-facing delivery structures. This operational continuity ensures that existing pharmaceutical client contracts and project timelines will remain unaffected, while giving SimoTech access to PerkinElmer's global network and resources to scale its automation solutions internationally.
William Fry Leads Multi-Jurisdictional Advisory Structure
Given the international scope of PerkinElmer’s operations and SimoTech's global client base, the transaction required a coordinated legal effort across multiple regulatory jurisdictions. William Fry acted as lead counsel to PerkinElmer, orchestrating the legal due diligence, transaction structuring, and contract negotiations.
The William Fry advisory team was led by Corporate Partner and Head of the London office, Ivor Banim, alongside Corporate Partner Fiachra Cork. The corporate legal team received support from Tax Partner Colin Bolger, who structured the cross-border tax considerations of the transaction, alongside a multi-disciplinary team of employment, intellectual property, and real estate specialists.
To address the international dimensions of the acquisition, William Fry collaborated with joint advisors in other key markets:
- Simpson Thacher & Bartlett: Advised PerkinElmer on all United States corporate, regulatory, and legal matters.
- Wong Partnership: Handled the Singaporean legal aspects, ensuring compliance with local corporate law and licensing rules.
This coordinated legal framework enabled the transaction to proceed smoothly through closing, ensuring that all intellectual property, client service agreements, and employment contracts across Ireland, the US, and Asia-Pacific were aligned.
SimoTech corporate headquarters leadership team. Image credit: www.sourcesimotechnology.com
Capabilities Comparison: Combined Industry Impact
To understand the industry impact of the acquisition, the table below highlights how the technical and operational profiles of Project Farma and SimoTech complement one another:
| Service Category | Project Farma (PerkinElmer) | SimoTech Group |
|---|---|---|
| Core Specialization | Commissioning, Qualification, Validation (CQV), Project Management | Manufacturing Automation, Distributed Control (DCS), MES, GMP IT |
| Engineering Focus | Physical facility startup, equipment validation, regulatory compliance | Software system design, control loop integration, data historization |
| IT System Expertise | Validation of IT systems, data integrity audits, CSV protocol drafting | Active system implementation, database scripting, cyber security architectures |
| Regulatory Compliance | FDA, EMA, HPRA audit readiness, CAPA management, quality oversight | Implementing 21 CFR Part 11 compliance, electronic signature protocols, audit trail design |
Outlook for the Irish Life Science Sector
The acquisition of SimoTech by a global brand like PerkinElmer highlights the strength of Ireland’s life sciences services ecosystem. Ireland is home to all top ten global pharmaceutical companies, and the supporting infrastructure of specialized engineering, automation, and legal firms is highly valued globally.
As pharmaceutical manufacturing moves toward Industry 4.0 concepts, incorporating artificial intelligence, real-time analytics, and advanced process controls, the automation engineering sector is expected to see continued consolidation. The integration of CQV and automation systems under one corporate umbrella will likely establish a new benchmark for capital project execution in Cork and other life science clusters globally.
Frequently Asked Questions
What systems does SimoTech specialize in?
SimoTech specializes in manufacturing automation and Good Manufacturing Practice (GMP) IT systems for the life sciences sector. This includes Distributed Control Systems (DCS), Manufacturing Execution Systems (MES), Supervisory Control and Data Acquisition (SCADA), and related data integration architectures.
Who founded SimoTech and where is it located?
SimoTech was founded in 2011 by Pat Desmond. The company is headquartered in Cork, Ireland, and operates as a prominent systems integrator and consulting partner for pharmaceutical and biotech companies.
Which law firms advised on the PerkinElmer acquisition of SimoTech?
William Fry acted as lead counsel and advised PerkinElmer on the acquisition. Simpson Thacher & Bartlett provided legal counsel regarding U.S. law, and Wong Partnership advised on Singaporean legal matters.
Will SimoTech continue to operate in Cork?
Yes. Following the transaction, SimoTech will continue its operations from its Cork offices, maintaining its current leadership team, engineering workforce, and existing customer relationships.
What is the relationship between Project Farma and PerkinElmer?
Project Farma is a division of PerkinElmer that specializes in commissioning, qualification, and validation (CQV) services, project management, and quality compliance for life science organizations.
